NIH Awards The Texas Heart Institute $1.14 Million to Develop a Novel, First-in-Class Drug for Atherosclerotic Cardiovascular Disease
HOUSTON (Aug. 22, 2023) — The National Heart, Lung, and Blood Institute (NHLBI) recently awarded The Texas Heart Institute® (THI)...

